Literature DB >> 31858966

Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: the MOVE IT three-arm RCT.

Khalida Ismail1, Daniel Stahl2, Adam Bayley1, Katherine Twist1, Kurtis Stewart1, Katie Ridge1, Emma Britneff1, Mark Ashworth3, Nicole de Zoysa1, Jennifer Rundle1, Derek Cook4, Peter Whincup4, Janet Treasure5, Paul McCrone6, Anne Greenough7, Kirsty Winkley1.   

Abstract

BACKGROUND: Motivational interviewing (MI) enhanced with behaviour change techniques (BCTs) and deployed by health trainers targeting multiple risk factors for cardiovascular disease (CVD) may be more effective than interventions targeting a single risk factor.
OBJECTIVES: The clinical effectiveness and cost-effectiveness of an enhanced lifestyle motivational interviewing intervention for patients at high risk of CVD in group settings versus individual settings and usual care (UC) in reducing weight and increasing physical activity (PA) were tested.
DESIGN: This was a three-arm, single-blind, parallel randomised controlled trial.
SETTING: A total of 135 general practices across all 12 South London Clinical Commissioning Groups were recruited. PARTICIPANTS: A total of 1742 participants aged 40-74 years with a ≥ 20.0% risk of a CVD event in the following 10 years were randomised.
INTERVENTIONS: The intervention was designed to integrate MI and cognitive-behavioural therapy (CBT), delivered by trained healthy lifestyle facilitators in 10 sessions over 1 year, in group or individual format. The control group received UC. RANDOMISATION: Simple randomisation was used with computer-generated randomisation blocks. In each block, 10 participants were randomised to the group, individual or UC arm in a 4 : 3 : 3 ratio. Researchers were blind to the allocation. MAIN OUTCOME MEASURES: The primary outcomes are change in weight (kg) from baseline and change in PA (average number of steps per day over 1 week) from baseline at the 24-month follow-up, with an interim follow-up at 12 months. An economic evaluation estimates the relative cost-effectiveness of each intervention. Secondary outcomes include changes in low-density lipoprotein cholesterol and CVD risk score.
RESULTS: The mean age of participants was 69.75 years (standard deviation 4.11 years), 85.5% were male and 89.4% were white. At the 24-month follow-up, the group and individual intervention arms were not more effective than UC in increasing PA [mean 70.05 steps, 95% confidence interval (CI) -288 to 147.9 steps, and mean 7.24 steps, 95% CI -224.01 to 238.5 steps, respectively] or in reducing weight (mean -0.03 kg, 95% CI -0.49 to 0.44 kg, and mean -0.42 kg, 95% CI -0.93 to 0.09 kg, respectively). At the 12-month follow-up, the group and individual intervention arms were not more effective than UC in increasing PA (mean 131.1 steps, 95% CI -85.28 to 347.48 steps, and mean 210.22 steps, 95% CI -19.46 to 439.91 steps, respectively), but there were reductions in weight for the group and individual intervention arms compared with UC (mean -0.52 kg, 95% CI -0.90 to -0.13 kg, and mean -0.55 kg, 95% CI -0.95 to -0.14 kg, respectively). The group intervention arm was not more effective than the individual intervention arm in improving outcomes at either follow-up point. The group and individual interventions were not cost-effective.
CONCLUSIONS: Enhanced MI, in group or individual formats, targeted at members of the general population with high CVD risk is not effective in reducing weight or increasing PA compared with UC. Future work should focus on ensuring objective evidence of high competency in BCTs, identifying those with modifiable factors for CVD risk and improving engagement of patients and primary care. TRIAL REGISTRATION: Current Controlled Trials ISRCTN84864870. FUNDING: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 69. See the NIHR Journals Library website for further project information. This research was part-funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.

Entities:  

Keywords:  CARDIOVASCULAR DISEASE; COGNITIVE–BEHAVIOURAL THERAPY; LIFESTYLE INTERVENTION; MOTIVATIONAL INTERVIEWING; PHYSICAL ACTIVITY; PRIMARY HEALTH CARE; WEIGHT LOSS

Mesh:

Year:  2019        PMID: 31858966      PMCID: PMC6943381          DOI: 10.3310/hta23690

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN: 1366-5278            Impact factor:   4.014


  129 in total

1.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

2.  Motivational interviewing delivered by diabetes educators: does it improve blood glucose control among poorly controlled type 2 diabetes patients?

Authors:  Garry Welch; Sofija E Zagarins; Rebecca G Feinberg; Jane L Garb
Journal:  Diabetes Res Clin Pract       Date:  2010-11-13       Impact factor: 5.602

3.  Exploring the impact of motivational interviewing training for qualified health visitors.

Authors:  Jo Hirdle; Tina Vaughan
Journal:  Community Pract       Date:  2016-08

4.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

5.  Reliable self-report of health service use by individuals with serious mental illness.

Authors:  Richard W Goldberg; Diana C Seybolt; Anthony Lehman
Journal:  Psychiatr Serv       Date:  2002-07       Impact factor: 3.084

6.  Cardiovascular disease risk profiles.

Authors:  K M Anderson; P M Odell; P W Wilson; W B Kannel
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

7.  Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

Authors:  Belgin Unal; Julia Alison Critchley; Simon Capewell
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

8.  How many days of monitoring predict physical activity and sedentary behaviour in older adults?

Authors:  Teresa L Hart; Ann M Swartz; Susan E Cashin; Scott J Strath
Journal:  Int J Behav Nutr Phys Act       Date:  2011-06-16       Impact factor: 6.457

9.  Comparing the effectiveness of an enhanced MOtiVational intErviewing InTervention (MOVE IT) with usual care for reducing cardiovascular risk in high risk subjects: study protocol for a randomised controlled trial.

Authors:  Adam Bayley; Nicole de Zoysa; Derek G Cook; Peter H Whincup; Daniel Stahl; Katherine Twist; Katie Ridge; Paul McCrone; Janet Treasure; Mark Ashworth; Anne Greenough; Clare Blythe; Kirsty Winkley; Khalida Ismail
Journal:  Trials       Date:  2015-03-25       Impact factor: 2.279

10.  The NHS Health Check in England: an evaluation of the first 4 years.

Authors:  John Robson; Isabel Dostal; Aziz Sheikh; Sandra Eldridge; Vichithranie Madurasinghe; Chris Griffiths; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2016-01-13       Impact factor: 2.692

View more
  3 in total

1.  The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults.

Authors:  Umar A R Chaudhry; Charlotte Wahlich; Rebecca Fortescue; Derek G Cook; Rachel Knightly; Tess Harris
Journal:  Int J Behav Nutr Phys Act       Date:  2020-10-09       Impact factor: 6.457

Review 2.  Physical activity, diet, and weight loss in patients recruited from primary care settings: An update on obesity management interventions.

Authors:  Louise de Lannoy; Theresa Cowan; Angela Fernandez; Robert Ross
Journal:  Obes Sci Pract       Date:  2021-05-04

3.  A framework for handling missing accelerometer outcome data in trials.

Authors:  Mia S Tackney; Derek G Cook; Daniel Stahl; Khalida Ismail; Elizabeth Williamson; James Carpenter
Journal:  Trials       Date:  2021-06-05       Impact factor: 2.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.